Perceive Pharma raised $15M in Series A funding to develop neuroprotective therapeutics for glaucoma and other conditions.

The asymptomatic nature of glaucoma makes it imperative to get consistent screening to catch the condition early. Catching glaucoma early through routine screening is the best way to get effective ...

SightScore is a saliva test that looks at millions of genetic variants in the patient’s genome to create a personalized ...

A glaucoma test includes a puff test, which measures the reaction of the eye to a concentrated but harmless puff of air. It also includes an eye pressure test, conducted by lightly touching the ...

This is a developing news story. Please check back soon for updates. Seonix Bio launched SightScore, a polygenic risk score ...

A systematic analysis finds Federally Qualified Health Centers can and should do more to expand vision care services, just as ...

It is important to look for specific signs of vision loss in children, and be proactive about routine visits to an eye ...

it's possible to have glaucoma within the 10-21 mmHg range. Pachymetry measures the thickness of the cornea. During the test, a provider will gently touch a small probe to the eye to take the ...

Up to 50% of glaucoma cases have a genetic component, a factor which could significantly change the screening recommendations and monitoring of patients – if they know their risk. Seonix Pty. Ltd. has ...